This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe

€600 savings expire in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

David Craig
CEO at Sarcomatrix Therapeutics Corp.
Presenter

Profile

At Sarcomatrix, we are pioneering treatments that address the root cause of muscle wasting diseases like sarcopenia, cachexia and muscular dystrophies. Our innovative approach combines gene-modifying oral drugs and protein replacement via IV, offering a potential cure rather than just symptom management.
This positions us uniquely in a market where there are no cures and existing treatments fall short.

Agenda Sessions

  • “Take a Chance on Me” Startup spotlight pitch competition

    15:00